Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: A systematic review

International Journal of Cardiology

Volumn 177, Issue 3, 2014, Pages 990-994

  Gracieux, Junève ^a   Sanders, Gillian D ^a   Pokorney, Sean D ^a,b   Lopes, Renato D ^a,b   Thomas, Kevin ^a,b   Al Khatib, Sana M ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Appropriate implantable cardioverter defibrillator therapies; Implantable cardioverter defibrillator; Incidence; Predictors; Systematic review

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CREATININE BLOOD LEVEL; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; KIDNEY DISEASE; PREDICTION; PRIMARY PREVENTION; SEX DIFFERENCE; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; TREATMENT INDICATION;

EID: 84920059248     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.170     Document Type: Article

References (33)

1. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 22 1997 1576 1583
2. K.H. Kuck, R. Cappato, J. Siebels, and R. Rüppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 7 2000 748 754
3. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, and H. Klein Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940
4. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease N Engl J Med 341 1999 1882 1890
5. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, and R. Boineau Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237
6. A.C. De ornelas maia, G. Soares-filho, V. Pereira, A.E. Nardi, and A.C. Silva Psychiatric disorders and quality of life in patients with implantable cardioverter defibrillators: a systematic review Prim Care Companion CNS Disord 15 2 2013
7. J.E. Poole, G.W. Johnson, A.S. Hellkamp, J. Anderson, D.J. Callans, and M.H. Raitt Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 10 2008 1009 1017
8. A. Verma, B. Sarak, A.J. Kaplan, R. Oosthuizen, M. Beardsall, and Z. Wulffhart Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy Pacing Clin Electrophysiol 33 3 2010 320 329
9. M.S. Kremers, S.C. Hammill, C.I. Berul, C. Koutras, J.S. Curtis, and Y. Wang The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011 Heart Rhythm 10 4 2013 e59 e65
10. J.P. Singh, W.J. Hall, S. McNitt, H. Wang, J.P. Daubert, and W. Zareba Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) J Am Coll Cardiol 46 9 2005 1712 1720
11. A.C. Ng, M. Bertini, C.J. Borleffs, V. Delgado, E. Boersma, and S.R. Piers Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy Am J Cardiol 106 11 2010 1566 1573
12. A.A. Alsheikh-Ali, M. Homer, P.V. Maddukuri, B. Kalsmith, N.A. Estes III, and M.S. Link Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy J Cardiovasc Electrophysiol 19 8 2008 784 789
13. M. Santini, M. Russo, G. Botto, M. Lunati, A. Proclemer, and B. Schmidt Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI) Europace 11 4 2009 476 482
14. J.B. van Rees, C.J.W. Borleffs, G.H. van Welsenes, E.T. van der Velde, J.J. Bax, and L. van Erven Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score Heart 98 11 2012 872 877
15. L. Nombela-Franco, C.D. Mitroi, I. Fernandez-Lozano, A. Garcia-Touchard, J. Toquero, and V. Castro-Urda Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study) Circ Arrhythm Electrophysiol 5 1 2012 147 154
16. L.H. Curtis, S.M. Al-Khatib, A.M. Shea, B.G. Hammill, A.F. Hernandez, and K.A. Schulman Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death JAMA 298 2007 1517 1524
17. A.F. Hernandez, G.C. Fonarow, L. Liang, S.M. Al-Khatib, L.H. Curtis, and K.A. LaBresh Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 2007 1525 1532
18. S.M. Al-Khatib, A. Hellkamp, A.F. Hernandez, G.C. Fonarow, K.L. Thomas, and H.R. Al-Khalidi Trends in use of implantable cardioverter defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation 125 2012 1094 1101
19. A.J. Gauri, A. Davis, T. Hong, M.C. Burke, and B.P. Knight Disparities in the use of primary prevention and defibrillator therapy among blacks and women Am J Med 119 2 2006 167.e17 167.e21
20. A.M. Russo, J.E. Poole, D.B. Mark, J. Anderson, A.S. Hellkamp, and K.L. Lee Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial J Cardiovasc Electrophysiol 19 2008 720 724
21. A.M. Russo, N.J. Stamato, M.H. Lehmann, G.E. Hafley, K.L. Lee, and K. Pieper Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial J Cardiovasc Electrophysiol 15 2004 993 998
22. W. Zareba, A.J. Moss, W. Jackson Hall, D.J. Wilber, J.N. Ruskin, and S. McNitt Clinical course and implantable cardioverter defibrillator therapy in post-infarction women with severe left ventricular dysfunction J Cardiovasc Electrophysiol 16 2005 1265 1270
23. N.L. Cook, E.J. Orav, C.L. Liang, E. Guadagnoli, and L.S. Hicks Racial and gender disparities in implantable cardioverter-defibrillator placement: are they due to overuse or underuse? Med Care Res Rev 68 2 2011 226 246
24. A.M. Russo, J.D. Day, K. Stolen, C.M. Mullin, V. Doraiswamy, and D.L. Lerew Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial J Cardiovasc Electrophysiol 20 2009 973 978
25. H. Ghanbari, G. Dalloul, R. Hasan, M. Daccarett, S. Saba, S. David, and C. Machado Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials Arch Intern Med 169 2009 1500 1506
26. P. Korantzopoulos, T. Liu, L. Li, J.A. Goudevenos, and G. Li Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis Europace 11 2009 1469 1475
27. J. Robin, K. Weinberg, J. Tiongson, M. Carnethon, M. Reddy, and C. Ciaccio Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients Heart Rhythm 3 2006 1196 1201
28. R. Sakhuja, M. Keebler, T.S. Lai, C. McLaughlin Gavin, R. Thakur, and D.L. Bhatt Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator Am J Cardiol 103 2009 735 741
29. M.P. Turakhia, P.D. Varosy, K. Lee, Z.H. Tseng, R. Lee, and N. Badhwar Impact of renal function on survival in patients with implantable cardioverter-defibrillators Pacing Clin Electrophysiol 30 2007 377 384
30. I. Goldenberg, A.J. Moss, S. McNitt, W. Zareba, M.L. Andrews, and W.J. Hall Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction Am J Cardiol 98 2006 485 490
31. P.L. Hess, A.S. Hellkamp, E.D. Peterson, G.D. Sanders, H.R. Al-Khalidi, and L.H. Curtis Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease Circ Arrhythm Electrophysiol 2014
32. J. Chen, G. Johnson, A.S. Hellkamp, J. Anderson, D.B. Mark, and K.L. Lee Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) J Am Coll Cardiol 61 21 2013 2161 2168
33. W.C. Members, A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A.M. Estes, and R.A. Freedman ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 21 2008 e350 e408